...
首页> 外文期刊>European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology >Radioguided occult lesion localisation (ROLL) and sentinel node biopsy for impalpable invasive breast cancer.
【24h】

Radioguided occult lesion localisation (ROLL) and sentinel node biopsy for impalpable invasive breast cancer.

机译:放射性隐匿性病变定位(ROLL)和前哨淋巴结活检对难治性浸润性乳腺癌。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

AIM: The aim of this study was to simplify the technique of ROLL and sentinel node biopsy without compromising tumour excision and sentinel node biopsy. METHODS: Twenty patients with impalpable primary invasive breast carcinoma underwent an injection of (99m)Tc-nanocolloid mixed with radiographic contrast medium Iohexol into the centre of the lesion under ultrasound or stereotactic guidance pre-operatively. No guidewire localisation was performed. Under general anaesthesia, a periareolar intradermal/subcutaneous injection of patent blue-V dye was performed. The sentinel node was identified by blue-stained lymphatics and node and a hot spot on the gamma probe. Surgical excision of the primary tumour was then carried out using the gamma probe. RESULTS: In eight of 20 cases an immediate re-excision was carried out and on histological assessment, all 20 patients were clear of invasive disease at the margins. In two patients, in situ disease was present at the margins and a further re-excision was thereforeperformed. The sentinel node was identified in all cases. In all, five of 20 patients were node positive on routine HE staining. In a further two patients, tumour cells were identified by immunohistochemistry with CAM5.2 antibody. Completion axillary clearance in six patients confirmed that the sentinel node was the only positive node. CONCLUSIONS: This modification of the previously described ROLL technique is feasible and safe and does not compromise tumour excision or sentinel node detection.
机译:目的:本研究的目的是简化ROLL和前哨淋巴结活检的技术,而又不影响肿瘤切除和前哨淋巴结活检。方法:20例原发性浸润性乳腺癌患者术前在超声或立体定向指导下,向病灶中心注射(99m)Tc-纳米胶体与放射造影剂碘海醇混合。没有进行导丝定位。在全身麻醉下,进行乳晕周围皮内/皮下注射漆蓝V染料。前哨淋巴结由蓝色染色的淋巴管和淋巴结及伽马探针上的热点识别。然后使用γ探针对原发肿瘤进行手术切除。结果:在20例中的8例中,立即进行了再次切除,并且根据组织学评估,所有20例患者在边缘均未发现侵袭性疾病。在两名患者中,边缘处存在原位疾病,因此进行了再次切除。在所有情况下都确定了前哨节点。总共20例患者中有5例常规HE染色为淋巴结阳性。在另外两名患者中,用CAM5.2抗体通过免疫组织化学鉴定了肿瘤细胞。六例患者的完全腋窝清除证实了前哨淋巴结是唯一的阳性淋巴结。结论:先前描述的ROLL技术的这种修改是可行和安全的,并且不会损害肿瘤切除或前哨淋巴结的检测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号